Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dalcelli、Exemestane、Gosserine|DRUG: Docetaxel for injection、Epirubicin hydrochloride for injection、Cyclophosphamide for injection
Sponsor: Tianjin Medical University Cancer Institute and Hospital